80 related articles for article (PubMed ID: 19538055)
1. Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
Bjurberg M; Henriksson E; Brun E; Ekblad L; Ohlsson T; Brun A; Kjellén E
Cancer Biother Radiopharm; 2009 Jun; 24(3):327-32. PubMed ID: 19538055
[TBL] [Abstract][Full Text] [Related]
2. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).
Molthoff CF; Klabbers BM; Berkhof J; Felten JT; van Gelder M; Windhorst AD; Slotman BJ; Lammertsma AA
Mol Imaging Biol; 2007; 9(6):340-7. PubMed ID: 17643202
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
Henriksson E; Kjellén E; Baldetorp B; Bendahl PO; Borg A; Brun E; Mertens F; Ohlsson T; Rennstam K; Wennerberg J; Wahlberg P
J Exp Clin Cancer Res; 2009 Feb; 28(1):17. PubMed ID: 19216775
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.
Haylock AK; Spiegelberg D; Mortensen AC; Selvaraju RK; Nilvebrant J; Eriksson O; Tolmachev V; Nestor MV
Int J Oncol; 2016 Feb; 48(2):461-70. PubMed ID: 26676731
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Vergez S; Delord JP; Thomas F; Rochaix P; Caselles O; Filleron T; Brillouet S; Canal P; Courbon F; Allal BC
Clin Cancer Res; 2010 Sep; 16(17):4434-45. PubMed ID: 20660574
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Minn H; Clavo AC; Grénman R; Wahl RL
J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
[TBL] [Abstract][Full Text] [Related]
7. 2-Deoxy-2-[18F] fluoro-D-glucose uptake and correlation to intratumoral heterogeneity.
Henriksson E; Kjellen E; Wahlberg P; Ohlsson T; Wennerberg J; Brun E
Anticancer Res; 2007; 27(4B):2155-9. PubMed ID: 17695498
[TBL] [Abstract][Full Text] [Related]
8. Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.
Simons AL; Fath MA; Mattson DM; Smith BJ; Walsh SA; Graham MM; Hichwa RD; Buatti JM; Dornfeld K; Spitz DR
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1222-30. PubMed ID: 17967311
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
[TBL] [Abstract][Full Text] [Related]
10. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
11. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
Reisser C; Haberkorn U; Strauss LG
J Otolaryngol; 1993 Aug; 22(4):231-8. PubMed ID: 8230373
[TBL] [Abstract][Full Text] [Related]
12. Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.
Bao A; Phillips WT; Goins B; McGuff HS; Zheng X; Woolley FR; Natarajan M; Santoyo C; Miller FR; Otto RA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):853-7. PubMed ID: 17141073
[TBL] [Abstract][Full Text] [Related]
13. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
[TBL] [Abstract][Full Text] [Related]
14. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
15. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Yoshioka T; Takahashi H; Oikawa H; Maeda S; Ido T; Akaizawa T; Fukuda H; Kanamaru R
J Nucl Med; 1997 May; 38(5):714-7. PubMed ID: 9170434
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
[TBL] [Abstract][Full Text] [Related]
17. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
[TBL] [Abstract][Full Text] [Related]
18. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
19. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
20. Sensitization by glycerol for CDDP-therapy against human cultured cancer cells and tumors bearing mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Yane K; Kanata H; Okamoto N; Hosoi H; Ohnishi T
Apoptosis; 2004 Nov; 9(6):853-9. PubMed ID: 15505427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]